Vo Lequang T, Armany David, Chalasani Venu, Bariol Simon V, Baskaranathan Sriskanthan, Hossack Tania, Ende David, Woo Henry H
Department of Urology, Blacktown Mount-Druitt Hospital, Sydney, NSW, Australia.
School of Medicine, Western Sydney University, Sydney, NSW, Australia.
Prostate Cancer Prostatic Dis. 2025 May 10. doi: 10.1038/s41391-025-00970-z.
Endoscopic enucleation of the prostate (EEP) has emerged as a leading surgical treatment for benign prostatic hyperplasia (BPH), traditionally managed by transurethral resection of the prostate (TURP). EEP involves complete adenoma removal along the surgical capsule and can be performed using different energy sources, such as holmium, thulium, GreenLight and diode lasers, or bipolar electrocautery. This meta-analysis compares the efficacy and safety of EEP versus TURP.
A comprehensive search of MEDLINE, EMBASE, CENTRAL, Web of Science, and Scopus (2003-present) identified randomised controlled trials (RCTs) comparing EEP with TURP in adult males (≥18 years) with BPH. Primary outcomes comprised functional measures (Qmax, PVR, IPSS, QoL, IIEF-5), while secondary outcomes included adverse events (incontinence, bleeding, infection, re-treatment rates, hospital stay duration). Two reviewers independently performed data extraction and assessed risk of bias using the Cochrane RoB2 tool.
Twenty-eight RCTs (n = 3085) met inclusion criteria: 1538 patients underwent EEP and 1547 underwent TURP. EEP was associated with significantly improved IPSS (at 12 months), Qmax (1, 6, 12, 24 months), and PVR (6, 12, 36 months) compared with TURP. Perioperative outcomes favoured EEP, including shorter catheterisation time (MD = -1.12 days), reduced hospital stay (MD = -0.92 days), and lower transfusion rates (RR = 0.22). No significant differences were observed in long-term incontinence or bladder neck contracture, though EEP yielded lower stricture rates (RR = 0.55) and reoperation rates for recurrent BPH (RR = 0.32). Heterogeneity was high in several outcomes, reflecting variability in patient characteristics, enucleation techniques, and surgeon experience.
EEP compares favourably with TURP for BPH, providing notable benefits in bleeding control, faster recovery and durable obstruction relief. Anatomical enucleation yields functional outcomes at least equal and often superior to TURP. Energy source choice may reflect resources and surgeon preferences. Future research should distinguish enucleation completeness from energy source.
前列腺内镜剜除术(EEP)已成为良性前列腺增生(BPH)的主要手术治疗方法,传统上BPH通过经尿道前列腺切除术(TURP)进行治疗。EEP包括沿手术包膜完整切除腺瘤,可使用不同的能量源进行,如钬激光、铥激光、绿激光和二极管激光,或双极电凝。本荟萃分析比较了EEP与TURP的疗效和安全性。
全面检索MEDLINE、EMBASE、CENTRAL、科学网和Scopus(2003年至今),以确定比较EEP与TURP治疗成年男性(≥18岁)BPH的随机对照试验(RCT)。主要结局包括功能指标(最大尿流率、残余尿量、国际前列腺症状评分、生活质量、国际勃起功能指数-5),次要结局包括不良事件(尿失禁、出血、感染、再次治疗率、住院时间)。两名研究者独立进行数据提取,并使用Cochrane RoB2工具评估偏倚风险。
28项RCT(n = 3085)符合纳入标准:1538例患者接受了EEP,1547例接受了TURP。与TURP相比,EEP在12个月时国际前列腺症状评分显著改善,在1、6、12、24个月时最大尿流率显著改善,在6、12、36个月时残余尿量显著改善。围手术期结局有利于EEP,包括导尿时间缩短(MD = -1.12天)、住院时间缩短(MD = -0.92天)和输血率降低(RR = 0.22)。长期尿失禁或膀胱颈挛缩方面未观察到显著差异,尽管EEP的尿道狭窄率较低(RR = 0.55),复发性BPH的再次手术率较低(RR = 0.32)。几个结局的异质性较高,反映了患者特征、剜除技术和外科医生经验的差异。
对于BPH,EEP与TURP相比具有优势,在控制出血、更快恢复和持久缓解梗阻方面具有显著益处。解剖学剜除术产生的功能结局至少与TURP相当,且往往优于TURP。能量源的选择可能反映资源和外科医生的偏好。未来的研究应区分剜除的完整性和能量源。